Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ADherence Assessment with Glivec: Indicators and Outcomes

Next Previous
Trial Profile

ADherence Assessment with Glivec: Indicators and Outcomes

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Imatinib (Primary)
  • Indications Chronic myeloid leukaemia; Gastrointestinal stromal tumours
  • Focus Therapeutic Use
  • Acronyms ADAGIO

    • Most Recent Events

    • 01 Dec 2021 Results (n=169) of post hoc analyses of the ADAGIO study published in the Leukemia Research
    • 08 Jun 2021 Results of a post hoc analysis aimed to model probabilistically the margin of tolerance required to ensure treatment response among patients prescribed Imatinib and the margin, if any, before treatment response is at risk presented at the 57th Annual Meeting of the American Society of Clinical Oncology
    • 09 Nov 2007 New trial record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top